arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Zoetis Inc.

ZTS Health Care Biotechnology: Pharmaceutical Preparations
$75.11
▼ -0.9% Today
as of Sep 4, 16:56 ET
Last 30 days -1.44% Jul 27 → Sep 04
$72.24 $73.77 $75.30 $76.82 $78.35 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$75.08
High
$75.84
Low
$74.83
Volume
$4M
Avg Vol
$5M
Mkt Cap
$31.3B
P/E (TTM)
16.46
Beta
—
52w High
$155.15
52w Low
$71.00
Div Yield
—
Shares Out
$414M

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 24 ▼ 1
Sep 3 · 11:56 Barchart neutral
Is Zoetis Stock Underperforming the S&P 500?
Sep 2 · 11:30 PR Business Wire neutral
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Aug 25 · 09:29 MT Newswires neutral
TD Cowen Adjusts Price Target on Zoetis to $94 From $104
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$71
$155
5% of range
Avg surprise (last 3)
+3.1%
Avg reaction (last 2)
-13.3%
0% positive
Latest IV / EM
32%
EM ±5.0% · $75 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.19$1.33$1.48$1.62$1.76 Actual $1.19Actual $1.45Actual $1.29Actual $1.31Actual $1.37Actual $1.50Actual $1.48Est $1.40Actual $1.76Est $1.62Actual $1.63Actual $1.53Est $1.61Actual $1.65 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$649M$1.3B$1.9B$2.6B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.65 — — — — financials
Thu May 7, 2026Mar/2026 $1.53 $1.61 -5.0% +3.4% -21.5% earnings
Tue Sep 30, 2025Sep 2025 $1.63 — — — — financials
Tue Aug 5, 2025Jun/2025 $1.76 $1.62 +8.6% — — earnings
Tue May 6, 2025Mar/2025 $1.48 $1.40 +5.7% — -5.2% earnings
Mon Sep 30, 2024Sep 2024 $1.50 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.37 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.31 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.29 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.45 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.19 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$2.47B$2.26B—$2.40B$2.47B$2.20B—$2.39B
Cost of revenue$673M$641M—$683M$664M$618M—$701M
Gross profit————————
Operating income————————
Net income$691M$601M—$721M$726M$602M—$682M
EPS (diluted)$1.65$1.42—$1.63$1.63$1.34—$1.50

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$1.48B$1.94B$2.45B$2.08B$1.44B$1.72B$1.99B$1.71B
Inventory$2.57B$2.55B$2.46B$2.46B$2.44B$2.37B$2.31B$2.42B
Total current assets$6.36B$6.47B$6.77B$6.58B$5.92B$5.88B$5.99B$6.28B
Total assets$15.08B$15.15B$15.49B$15.16B$14.48B$14.10B$14.24B$14.36B
Long-term debt$9.05B$9.04B$9.04B$7.07B$5.23B$5.23B$5.22B$6.57B
Total liabilities$11.93B$11.92B$12.07B$9.76B$9.50B$9.44B$9.47B$9.12B
Total equity$3.15B$3.23B$3.42B$5.40B$5.16B$4.87B$4.77B$5.23B

Implied volatility — last 90 days

29%60%90%121%151% Jun 07 — IV 43% · EM ±5.9%Jun 08 — IV 43% · EM ±5.7%Jun 09 — IV 44% · EM ±5.5%Jun 10 — IV 42% · EM ±5.0%Jun 11 — IV 41% · EM ±4.5%Jun 12 — IV 35% · EM ±3.5%Jun 15 — IV 47% · EM ±3.4%Jun 16 — IV 49% · EM ±2.9%Jun 17 — IV 152% · EM ±6.3%Jun 19 — IV 36% · EM ±7.9%Jun 22 — IV 34% · EM ±7.0%Jun 23 — IV 35% · EM ±7.2%Jun 24 — IV 39% · EM ±7.7%Jun 25 — IV 35% · EM ±6.8%Jun 26 — IV 34% · EM ±6.5%Jun 29 — IV 34% · EM ±6.0%Jun 30 — IV 38% · EM ±6.6%Jul 01 — IV 44% · EM ±7.4%Jul 02 — IV 30% · EM ±4.8%Jul 03 — IV 31% · EM ±4.8%Jul 06 — IV 37% · EM ±5.1%Jul 07 — IV 38% · EM ±5.0%Jul 08 — IV 36% · EM ±4.5%Jul 09 — IV 32% · EM ±3.8%Jul 10 — IV 30% · EM ±3.3%Jul 13 — IV 38% · EM ±3.2%Jul 14 — IV 47% · EM ±3.4%Jul 15 — IV 39% · EM ±2.3%Jul 16 — IV 74% · EM ±3.1%Jul 20 — IV 49% · EM ±11.6%Jul 21 — IV 51% · EM ±11.7%Jul 22 — IV 52% · EM ±12.0%Jul 23 — IV 52% · EM ±11.7%Jul 24 — IV 52% · EM ±11.5%Jul 27 — IV 55% · EM ±11.4%Jul 28 — IV 57% · EM ±11.6%Jul 29 — IV 57% · EM ±11.3%Jul 30 — IV 55% · EM ±10.8%Jul 31 — IV 58% · EM ±11.1%Aug 03 — IV 64% · EM ±11.4%Aug 04 — IV 69% · EM ±11.8%Aug 05 — IV 74% · EM ±12.3%Aug 06 — IV 41% · EM ±6.6%Aug 07 — IV 39% · EM ±6.2%Aug 10 — IV 37% · EM ±5.2%Aug 11 — IV 38% · EM ±5.0%Aug 12 — IV 38% · EM ±4.7%Aug 13 — IV 44% · EM ±5.2%Aug 14 — IV 35% · EM ±3.9%Aug 17 — IV 48% · EM ±4.0%Aug 18 — IV 41% · EM ±3.0%Aug 19 — IV 52% · EM ±3.1%Aug 20 — IV 38% · EM ±1.6%Aug 24 — IV 37% · EM ±7.7%Aug 25 — IV 36% · EM ±7.5%Aug 26 — IV 38% · EM ±7.5%Aug 27 — IV 33% · EM ±6.4%Aug 28 — IV 36% · EM ±7.0%Aug 31 — IV 35% · EM ±6.2%Sep 01 — IV 36% · EM ±6.2%Sep 02 — IV 34% · EM ±5.6%Sep 03 — IV 35% · EM ±5.7%Sep 04 — IV 32% · EM ±5.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in